Title : Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.

Pub. Date : 2017 May

PMID : 28284718






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Proliferation of Ba/F3 cells transduced with novel JAK3 mutations (JAK3H583Y and JAK3G589D) was independent of IL-3 and was inhibited by the JAK3 inhibitor tofacitinib (means +- SD drug concentration causing a 50% inhibition of the desired activity, 85 +- 10 nmol/L and 54 +- 9 nmol/L). tofacitinib Janus kinase 3 Mus musculus
2 Proliferation of Ba/F3 cells transduced with novel JAK3 mutations (JAK3H583Y and JAK3G589D) was independent of IL-3 and was inhibited by the JAK3 inhibitor tofacitinib (means +- SD drug concentration causing a 50% inhibition of the desired activity, 85 +- 10 nmol/L and 54 +- 9 nmol/L). tofacitinib Janus kinase 3 Mus musculus